工程 ACE2 蛋白质的竞争性结合的分子见解和优化策略:多重复制分子动力学研究
Jiahao Sun1, Xinguo Liu1, Shaolong Zhang1
1School of Physics and Electronics, Shandong Normal University, Jinan, 250358, China. liuxinguo@sdnu.edu.cn.
Physical chemistry chemical physics : PCCP
|October 17, 2023
概括
通过改变结合机制,工程 ACE2 变种在抑制 SARS-CoV-2 感染方面表现有前途. 确定了优化策略,以提高有效性,并防止免疫系统从不断变化的病毒变体中逃脱.
科学领域:
- 病毒学 病毒学
- 生物化学 生化学
- 计算生物学 计算生物学
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行正在进行中,病毒演变和新变种带来了重大控制挑战.
- SARS-CoV-2尖端蛋白的受体结合域 (RBD) 与人类的ACE2结合,这是病毒进入的关键步骤.
- 工程 ACE2 变种可以通过与野生型 ACE2 结合竞争来潜在地抑制感染.
研究的目的:
- 通过分子动力学模拟,研究工程 ACE2 变体 (3N39 和 3N94) 的机制.
- 确定优化工程 ACE2 的策略,以改善结合和减少病毒逃逸.
- 了解工程 ACE2 如何与不同的 RBD 变体相互作用.
主要方法:
- 多重复制分子动力学 (MRMD) 模拟用于分析工程 ACE2 变体.
- 分析的重点是ACE2-RBD接口的结合亲缘关系,结构重组,静电潜力和键网络.
- 在ACE2和RBD中确定影响结合并可被工程设计的关键残留物.
主要成果:
- 改造后的ACE2对具有较弱野生型ACE2结合的RBD变体 (例如,WT和BA.1 RBD) 显示出更高的疗效.
- 在工程 ACE2 的修改改变了静电分布和结,导致改变了 RBD 结合,尽管在所有 RBD 变体中不一致.
- 确定了工程ACE2和RBD的特定有益和有害残留物.
结论:
- 工程 ACE2 变种提供了针对 SARS-CoV-2 的潜在策略,其机制涉及改变的结合接口.
- 优化特定残留物可以提高工程 ACE2 的结合竞争力,并提供抗病毒免疫逃逸的抵抗力.
- 这些发现为开发用于疫情控制的先进工程 ACE2 蛋白质提供了基础.
相关概念视频
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein-Drug Binding: Mechanism and Kinetics
537
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
537
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
The Equilibrium Binding Constant and Binding Strength
13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K


